...
首页> 外文期刊>Journal of the Egyptian Society of Parasitology >EVALUATION OF A NEW ENZYME IMMUNOASSAY FOR THE DETECTION OF HELICOBACTER PYLORI IN STOOL SPECIMENS
【24h】

EVALUATION OF A NEW ENZYME IMMUNOASSAY FOR THE DETECTION OF HELICOBACTER PYLORI IN STOOL SPECIMENS

机译:一种用于检测样本中幽门螺杆菌的新酶联免疫法的评估

获取原文
获取原文并翻译 | 示例

摘要

H. pylori infects the gastric mucosa and causes many digestive disorders such as peptic ulcer, chronic gastritis and gastric cancer. H. pylori infection relates neither to functional health status, nor to intensity of dyspepsia. There is evidence that in most patients with H. pylori positive functional dyspepsia do not improve with eradication of the organism.This study evaluated the diagnostic accuracy of HpSA by determining the sensitivity and specificity of the stool antigen test in predicting suc cessful eradication during and after anti microbial therapy. The work was conducted on patients who underwent upper gastrointestinal endoscopy at Al-Azhar University hospitals. Fifty patients (34 male & 16 female) with dyspepsia were selected, the exclus ion criteria included use of antibiotics and proton pump inhibitors up to one month before the study. All cases were submitted to, full history, general and local examination and upper gastrointestinal endoscopy. Biopsies were taken from the antrum and b ody of the stomach for rapid urease test and histopathology. Stool samples were taken to detect H. pylori stool antigen. Positive patients received eradication treatment for one month and H. pylori status was re-determined by rapid urease test, histologi cal examination and HpSA test one month later. H. pylori was detected by rapid urease test in 29 (58%) dyspeptic patient by histology in 26(52%) dyspeptic patient, while H. pylori was detected by HpSA immunoassay in 16 (32%) dyspeptic patient. The sensit ivity and specificity of HpSA were 57.7% and 95.8% respectively. After successful eradication of H. pylori, reassessment by rapid urease test and histology revealed curative rate of 86.2% and 84.6% respectively, while HpSA immunoassay revealed curative r ate 75%. Based on these results, the HpSA immunoassay gave sensitivity (75%) and specificity (100%). The H. pylori stool test represents an accurate and novel non-invasive concept for diagnosis of infection and can be used for daily routine in clinical p ractice. HpSA is a promising non-invasive test for diagnosis of H. pylori infection but may be hampered by low patient acceptability. So, HpSA is a valuable test in the pre-and post eradication assessment of infection. HpSA can be profitably employed in the primary diagnosis of H. pylori infection. This non invasive test could be very useful in investigating dyspeptic young patients. Also, it could be used profitably in epidemiological studies to determine the prevalence of H. pylori infection in the as ymptomatic subjects in different communities.
机译:幽门螺杆菌感染胃粘膜并引起许多消化系统疾病,例如消化性溃疡,慢性胃炎和胃癌。幽门螺杆菌感染既与功能健康状况无关,也不与消化不良的强度有关。有证据表明,在大多数幽门螺杆菌阳性功能性消化不良患者中,根除该病原体并不能改善病情。这项研究通过确定粪便抗原测试在预测成功根除期间和之后是否成功的敏感性和特异性来评估HpSA的诊断准确性。抗微生物治疗。这项工作是在Al-Azhar大学医院对接受上消化道内镜检查的患者进行的。选择了50例消化不良的患者(男34例,女16例),排除标准包括在研究前一个月使用抗生素和质子泵抑制剂。所有病例均接受完整病史,全面和局部检查以及上消化道内镜检查。从胃的胃窦和胃底取出活检组织进行快速尿素酶检测和组织病理学检查。采集粪便样品以检测幽门螺杆菌粪便抗原。阳性患者接受了一个月的根除治疗,一个月后通过快速尿素酶检测,组织学检查和HpSA检测重新确定了幽门螺杆菌的状况。通过快速尿素酶测试在29例(58%)消化不良患者中通过组织学检测到幽门螺杆菌,在26例(52%)消化不良患者中通过组织学检测,而在16例(32%)消化不良患者中通过HpSA免疫测定法检测到幽门螺杆菌。 HpSA的敏感性和特异性分别为57.7%和95.8%。成功根除幽门螺杆菌后,通过快速尿素酶测试和组织学的重新评估,治愈率分别为86.2%和84.6%,而HpSA免疫测定显示治愈率为75%。根据这些结果,HpSA免疫测定可得出灵敏度(75%)和特异性(100%)。幽门螺杆菌粪便测试代表了一种准确,新颖的无创性概念,可用于诊断感染,可用于临床实践中的日常工作。 HpSA是用于诊断幽门螺杆菌感染的有前途的非侵入性检测方法,但可能因患者的可接受性低而受阻。因此,HpSA是根除感染前后的评估中有价值的测试。 HpSA可用于幽门螺杆菌感染的初步诊断。这项非侵入性测试在调查消化不良的年轻患者中可能非常有用。而且,它可以在流行病学研究中有利地用于确定幽门螺杆菌感染在不同社区的无症状受试者中的患病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号